Publication: Reply to Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, et al.'s letter to the editor re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. prostate-specific antigen level at the time of salvage therapy after radical prostatectomy for prostate cancer and the risk of death. J Clin Oncol 2023;41:2428-35
dc.contributor.coauthor | Chen MH, D'Amico AV. | |
dc.contributor.department | KUH (Koç University Hospital) | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Tilki, Derya | |
dc.contributor.schoolcollegeinstitute | KUH (KOÇ UNIVERSITY HOSPITAL) | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-12-29T09:37:17Z | |
dc.date.issued | 2023 | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 1 | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.volume | 7 | |
dc.identifier.doi | 10.1016/j.euo.2023.05.009 | |
dc.identifier.eissn | 2588-9311 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85184344466 | |
dc.identifier.uri | https://doi.org/10.1016/j.euo.2023.05.009 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/22306 | |
dc.identifier.wos | 1169977400001 | |
dc.keywords | Humans | |
dc.keywords | Male | |
dc.keywords | Prostate | |
dc.keywords | Prostate-specific antigen | |
dc.keywords | Prostatectomy | |
dc.keywords | Prostatic neoplasms surgery | |
dc.keywords | Salvage therapy | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | European Urology Oncology | |
dc.subject | Oncology | |
dc.subject | Urology and nephrology | |
dc.title | Reply to Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, et al.'s letter to the editor re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. prostate-specific antigen level at the time of salvage therapy after radical prostatectomy for prostate cancer and the risk of death. J Clin Oncol 2023;41:2428-35 | |
dc.type | Letter | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Tilki, Derya | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit1 | KUH (KOÇ UNIVERSITY HOSPITAL) | |
local.publication.orgunit2 | KUH (Koç University Hospital) | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isParentOrgUnitOfPublication | 055775c9-9efe-43ec-814f-f6d771fa6dee | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 055775c9-9efe-43ec-814f-f6d771fa6dee |